Ubs Group Ag Palatin Technologies Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$0.27 - $0.5 $1,948 - $3,607
-7,215 Reduced 68.77%
3,277 $1,000
Q1 2022

May 16, 2022
BUY
$0.37 - $0.54 $3,647 - $5,323
9,858 Added 1554.89%
10,492 $5,000
Q4 2021

Feb 14, 2022
SELL
$0.34 - $0.86 $2,813 - $7,115
-8,274 Reduced 92.88%
634 $0
Q3 2021

Nov 15, 2021
SELL
$0.44 - $0.63 $5,470 - $7,833
-12,434 Reduced 58.26%
8,908 $3,000
Q2 2021

Aug 13, 2021
SELL
$0.48 - $0.72 $8,197 - $12,296
-17,079 Reduced 44.45%
21,342 $13,000
Q1 2021

May 12, 2021
BUY
$0.68 - $1.25 $21,641 - $39,782
31,826 Added 482.58%
38,421 $26,000
Q4 2020

Feb 11, 2021
SELL
$0.38 - $0.78 $31,335 - $64,321
-82,463 Reduced 92.59%
6,595 $4,000
Q3 2020

Nov 12, 2020
BUY
$0.47 - $0.64 $35,612 - $48,493
75,771 Added 570.26%
89,058 $43,000
Q2 2020

Jul 31, 2020
SELL
$0.41 - $0.73 $70,097 - $124,807
-170,969 Reduced 92.79%
13,287 $6,000
Q1 2020

May 01, 2020
SELL
$0.36 - $0.79 $36,707 - $80,552
-101,965 Reduced 35.62%
184,256 $78,000
Q4 2019

Feb 14, 2020
BUY
$0.75 - $0.89 $80,469 - $95,490
107,293 Added 59.96%
286,221 $224,000
Q3 2019

Nov 14, 2019
BUY
$0.78 - $1.09 $103,638 - $144,828
132,870 Added 288.48%
178,928 $162,000
Q2 2019

Aug 14, 2019
BUY
$0.98 - $1.64 $36,240 - $60,647
36,980 Added 407.36%
46,058 $54,000
Q1 2019

May 14, 2019
SELL
$0.67 - $1.01 $46,746 - $70,468
-69,771 Reduced 88.49%
9,078 $9,000
Q4 2018

Feb 14, 2019
BUY
$0.63 - $1.0 $3,645 - $5,787
5,787 Added 7.92%
78,849 $56,000
Q3 2018

Nov 14, 2018
BUY
$0.88 - $1.1 $40,582 - $50,727
46,116 Added 171.14%
73,062 $73,000
Q2 2018

Aug 14, 2018
BUY
$0.91 - $1.45 $20,809 - $33,158
22,868 Added 560.77%
26,946 $26,000
Q1 2018

May 15, 2018
SELL
$0.84 - $1.18 $17,786 - $24,985
-21,174 Reduced 83.85%
4,078 $4,000
Q4 2017

Feb 14, 2018
BUY
$0.68 - $1.0 $5,059 - $7,441
7,441 Added 41.78%
25,252 $22,000
Q3 2017

Nov 14, 2017
BUY
$0.39 - $0.66 $5,901 - $9,987
15,133 Added 565.09%
17,811 $12,000
Q2 2017

Aug 14, 2017
SELL
N/A
-51,148 Reduced 95.02%
2,678 $1,000
Q1 2017

Nov 14, 2017
BUY
N/A
53,826
53,826 $18,000

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About PALATIN TECHNOLOGIES INC

PTN Quotes by TradingView
  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $9.76M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email